|
Match
|
Document |
Document Title |
|
|
7632836 |
Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
The present embodiments are related to the compound of Formula 1 or Formula 2 below and pharmaceutical formulations thereof as well as treatments for a wide variety of Central Nervous System...
|
|
|
7622117 |
3-deoxyglucosone and skin
The invention relates to a method of removing 3-deoxyglucosone and other alpha-dicarbonyl sugars from skin. The invention further relates to methods of inhibiting production and function of...
|
|
|
7563819 |
Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
The invention provides compounds for use in photochemotherapy or diagnosis, said compounds being branched alkyl esters or substituted alkyl esters of 5-aminolevulinic acid, or derivatives or...
|
|
|
7550625 |
Esters of florfenicol
The invention relates to compounds of formula (I):
wherein R is —C(O)CH 2 OCH 2 CH 2 OCH 3 or —C(O)CH 2 N(CH 3 ) 2 . The invention also relates to pharmaceutical compositions comprising a...
|
|
|
7530461 |
Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R22N—CH2COCH2-CH2CO—OR1...
|
|
|
7465820 |
Abiotic heparin antagonists
The present invention relates to heparin-binding calixarene compounds of general Formula (I) in which R, R 1 , L and n have the meanings indicated in the description and their use in the biomedical...
|
|
|
7459581 |
Anti-bacterial compounds
Ester compounds of the formula I-a
wherein R 1 is selected from OH, NH 2 and NH 3 + X − , wherein X is an inorganic anion, wherein R 2 is a singly-branched saturated or unsaturated...
|
|
|
7384980 |
Derivatives of 3,3-diphenylpropylamines
The invention concerns novel derivatives of 3,3-diphenylpropylamines, methods for their preparation, pharmaceutical compositions containing the novel compounds, and the use of the compounds for...
|
|
|
RE40246 |
Method for the suppression of viral growth
A method for suppressing undesired viral growth in a host which comprises administering to the host an effective amount of a compound of the formula:
wherein R 1 , R 2 , R 3 and R 4 are...
|
|
|
7335685 |
Crystals of ladostigil tartrate, methods of production and pharmaceutical compositions thereof
Disclosed is crystalline ladostigil tartrate of a specified density, compositions, including pharmaceutical compositions comprising such ladostigil tartrate, and a process for the manufacture thereof.
|
|
|
7287646 |
Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R 2 2 N—CH 2 COCH 2 —CH 2...
|
|
|
7226916 |
Preparation for the prevention and/or treatment of vascular disorders
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
fraction a) consisting of long chain...
|
|
|
7196117 |
Use of cationic surfactant as activity enhancer in deodorants and oral care
Antimicrobial system which comprises a cationic surfactant, derived from the condensation of fatty acids and esterified dibasic amino acids, according to the following formula (I), where: X is Br,...
|
|
|
7067545 |
Remedies for spinocerebellar ataxia and compositions for treating spinocerebellar ataxia
Remedies for spinocerebellar degeneration or compositions for treating the same which contain as the active ingredient one or more members selected from among D-cycloserine, D-serine esters,...
|
|
|
7037515 |
Anhydrous insect repellent composition
There is provided a topical composition that comprises (a) a substantially anhydrous insect repellent selected from the group consisting of ethyl 3 -(N-butylacetylamino) propionate or a derivative...
|
|
|
6969521 |
Aerosol insect repellent composition having low VOC content and method of applying same to the skin
Disclosed is an aerosol insect repellent composition. The composition has (a) an amount of an insect repellent effective to repel insects when applied to the skin and (b) a cosmetically-acceptable...
|
|
|
6905671 |
Diagnostic agents and remedies for malignant tumors
An agent for diagnosing or photokinetically treating malignant tumors, comprising as an active ingredient a compound in which at least one carbon atom of 5-aminolevulinic acid is a carbon isotope...
|
|
|
6903052 |
Nematicidal compositions and methods
The invention concerns the use of certain compounds related to fatty acids to control nematodes that infest plants or the situs of plants. Nematodes that parasitize animals can also be controlled...
|
|
|
6864285 |
Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the CB2 cannabinoid receptor
The present invention relates to novel covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids with aminoalcohols of general formula (I) which can usefully be used as...
|
|
|
6858649 |
Selective potentiation of serotonin receptor subtypes
The selective potentiation and/or inhibition of the 5-HT 2A and/or 5-HT 1A response to serotonin (5-HT) is achieved using analogs of oleamide. Selective potentiation and/or inhibition of the 5-HT...
|
|
|
6858650 |
Stable salts of novel derivatives of 3,3-diphenylpropylamines
The present invention concerns highly pure, crystalline, stable compounds of novel derivatives of 3,3-diphenylpropylamines in the form of their salts, a method for the manufacture and highly pure,...
|
|
|
6838471 |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
A method of inhibiting the release of a proinflammatory cytokine in a cell is disclosed. The method comprises treating the cell with a cholinergic agonist. The method is useful in patients at risk...
|
|
|
6806261 |
Methods for treating certain diseases using naaladase inhibitors
The present invention relates to methods for regulating the release of TGF-β from living cells in vitro or in vivo, comprising bringing the cells into contact with an effective amount of a...
|
|
|
6777444 |
Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives
Use of nordihydroguaiaretic derivatives to suppress CDC-2 and survivin, stimulate apoptosis, and treat tumors.
|
|
|
6761898 |
Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
The present invention relates to a composition, which contains L-carnitine or alkanoyl-L-carnitine, and a glucosaminoglycan or a constituent thereof, suitable for the prevention of articular...
|
|
|
6692774 |
Synergistic mixtures of selected amino acids
Novel synergistic fungicidal compositions used for protecting seeds, plants and other vegetative material against fungi contain a mixture of one or more compounds selected from group A and one or...
|
|
|
6646011 |
Insect repellant compositions
The present invention relates to insect repellant compositions containing, based upon the total weight of the composition, from about 6 to about 30 percent by weight of insect repellant active...
|
|
|
6624142 |
Trimethyl lock based tetrapartate prodrugs
The invention is directed primarily to compounds of Formula I: wherein: R 1 is a polymeric residue; L 1 is a bifunctional linking group; Y 1 and Y 2 are independently O, S or NR 7 ; R 2-7 ...
|
|
|
6608108 |
Method for treatment of tumors using nordihydroguaiaretic acid derivatives
Use of nordihydroguaiaretic derivatives to suppress CDC-2 and survivin, stimulate apoptosis, and treat tumors.
|
|
|
6602690 |
Process for production of dihomo-&ggr -linolenic acid and lipid containing same
A process for the production of dihomo-γ-linolenic acid comprising the steps of culturing a microorganism having an ability to produce araquidonic acid and having a reduced or lost Δ5 desaturase...
|
|
|
6552070 |
Health food useful for preventing liver and biliary dysfunctions containing an alkanoyl L-carnitine and Silybum marianum extract
A health food/dietary supplement is disclosed, endowed with a protective action on liver function against exogenous and endogenous hepatoxic agents, the characterizing components of which are...
|
|
|
6548469 |
Cleaning compositions
The present invention relates to cleaning compositions which comprise the insect repellent ethyl 3-(N-butylacetamino)propionate and the use of this insect repellent in all types of cleaning...
|
|
|
6495597 |
Cytostatic agents
Compounds of formula (I) wherein R 4 is an ester or thioester group and R, R 1 , R 2 and R 3 are as defined in the specification, inhibit proliferation of tumor cells.
|
|
|
6441035 |
Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
Heteroatom-interrupted HETE derivatives and methods of their use for treating dry eye are disclosed.
|
|
|
6417234 |
Nordihydroguaiaretic derivatives for use in treatment of tumors
Nordihydroguaiaretic acid derivatives and methods of use thereof for the treatment of tumors.
|
|
|
6353012 |
15-Hydroxyeicosatetraenoic acid-related compounds and methods of use
HETE derivatives and methods of their use for treating dry eye are disclosed.
|
|
|
6350782 |
Use of basic amino acids derivatives for lowering ceramide levels
The present invention provides methods for treating a cellular disorder in a mammal which is induced by elevated levels of ceramide by administering a basic amino acid, acylated basic amino acid,...
|
|
|
6346547 |
N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith
Low-toxicity, highly-bioavailable, pharmaceutical antioxidant compositions for preferred oral administration to mammals are provided which have at least one amino acid-based compound of the general...
|
|
|
6337349 |
Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
Solid and non hygroscopic salts consisting of lower alkanoyl L-carnitine magnesium citrates are disclosed which are suitable for preparing solid composition useful as dietary/nutritional...
|
|
|
6306881 |
Anti-inflammatory agents
Compounds of general formula (I) ##STR1## wherein R 4 is an ester or thioester group and R, R 1 , R 2 , and R 3 are as specified in the description, inhibit intracellular Leukotriene A 4 ...
|
|
|
6306905 |
Stable aqueous formulation of 3-(N-butylacetamino)-propionic acid ethyl ester
The present invention relates to stable aqueous formulations of the insect repellent ethyl 3-(N-butyl-acetamino)propionate.
|
|
|
6303569 |
Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
The present invention is directed to double prodrugs containing polymeric-based transport forms. These polymeric compounds comprise the formula: ##STR1## wherein: B is H, OH, OSiR 13 , a...
|
|
|
6217914 |
Ascorbic acid composition and method for treatment of aging or damaged skin
An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which...
|
|
|
6214874 |
Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
A method for using nordihydroguiaretic acid derivatives, in particular tetramethyl nordihydroguiaretic acid and tetraglycinal nordihydroguiaretic acid, for the localized treatment of tumors induced...
|
|
|
6207173 |
Lysine derivatives containing an Nε-alkoxy or Nε-alkenoxycarbonyl group, their preparation and their use in cosmetic, pharmaceutical, hygiene or food compositions
Lysine derivatives, salts of the derivatives, their optical isomers of D or L configuration, or their mixtures, the derivatives containing an N e -alkoxy or N e -alkenoxycarbonyl group and having...
|
|
|
6207710 |
Compounds for inhibiting β-amyloid peptide release and/or its synthesis
Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions...
|
|
|
6201020 |
Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
This invention relates to compounds, pharmaceutical compositions, and methods of using compounds of the formula: ##STR1## A is O or S; R is C 1 -C 10 straight or branched chain alkyl, C 2 ...
|
|
|
6201023 |
Methods and compositions to protect crops against plant parasitic nematodes
A method for protecting a crop against plant-parasitic nematode attack by inducing local and systemic resistance of the crop comprising the application of a composition containing an effective...
|
|
|
6194458 |
Benzamide potassium channel inhibitors
This invention relates to benzamide potassium channel inhibitors of general structural Formula I. ##STR1## The compounds of this invention are useful in the treatment of autoimmune diseases, the...
|
|
|
6191117 |
Methods of producing weight loss and treatment of obesity
Methods are disclosed for the acute and chronic treatment of obesity using drugs whose mechanism includes the interaction and antagonism of the kainate/AMPA receptor. Methods are disclosed for...
|